Skip to main content

Test Price

1,800 AED

✅ Home Collection Available

Acute Leukemia Panel in UAE – 1800 AED – Clinical Diagnostic Test

Executive Summary & Core Metrics

✅ Accuracy Guarantee

99.9% Diagnostic Sensitivity via ISO‑Certified Processing (ISO 9001:2015). Multiparametric Flow Cytometry with EuroFlow standardisation eliminates inter‑laboratory variability.

🏥 Extraction & Logistics

Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Immediate cold‑chain transport to the laboratory.

📞 Clinical Guidance

Telephonic Post‑Test Clinical Guidance in result interpretation. Direct line to a DHA‑licensed specialist for actionable next steps.

💳 Insurance Support

Direct Billing Verification via WhatsApp +971 54 548 8731. We handle pre‑approval with all major UAE insurers.

🏛️ Corporate Oversight

Performed at DNA Labs UAE, DHA Facility License 1143. Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.

Test Overview & Methodology

Acute Leukemia Panel (Multiparametric Flow Cytometry) is the definitive immunophenotypic test for diagnosing and classifying acute leukaemias – acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL) and mixed‑phenotype acute leukaemia (MPAL). The panel uses multiparametric flow cytometry to accurately identify and classify leukaemia cells in bone marrow or peripheral blood.

Feature Our Test (Acute Leukemia Panel) Closest Alternative
Methodology Multiparametric Flow Cytometry (EuroFlow 8‑colour MRD panel) Standard 4‑colour Flow Cytometry
Diagnostic Precision >99.9% sensitivity; discrimination of AML, ALL, MPAL, and minimal residual disease (MRD) 80–90% sensitivity; limited subclassification
Turnaround Time 1–2 days (expedited report available) 3–5 days
Accreditation ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) · DHA Licensed Facility 1143 Variable; often lacks ISO certification for flow cytometry
Price 1800 AED 1500–2200 AED (unstandardised)

Physician Insight & Safety Protocols

“This Acute Leukemia Panel provides detailed immunophenotypic data essential for accurate classification of acute leukaemias. As a diagnostic radiologist, I appreciate how flow cytometry complements imaging and morphological findings. Please remember that results must be interpreted alongside bone marrow morphology, cytogenetics, and clinical history. I encourage patients to review findings with their haematologist‑oncologist for personalised treatment planning.”

— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology · DHA Registration ID: 61713011

Advisory Notice

Medication Safety Warning

Do not discontinue prescribed medication without consulting your doctor.

Stopping corticosteroids, immunosuppressants, or anticoagulants abruptly may cause serious harm. Always schedule a pre‑test consultation to review your current therapies.

Exclusion Criteria & Emergency Red Flags

Criteria for Test Deferral

  • Sample unsuitability: clotted bone marrow, sample volume <1 mL, or delayed transport (>4 hours without cold chain).
  • Recent therapy interference: chemotherapy or monoclonal antibody treatment within 14 days may alter antigen expression – reschedule after 2‑week washout.
  • Active infection: febrile neutropenia or uncontrolled sepsis; stabilise first in an emergency setting before elective testing.
  • Pregnancy: panel is not recommended unless urgently indicated; discuss with maternal‑fetal medicine specialist.
  • Seek emergency care immediately: if you experience sudden severe bone pain, uncontrolled bleeding, confusion, or difficulty breathing – go to the nearest ER.

Patient FAQ & Clinical Guidance

1. What exactly does the Acute Leukemia Panel detect?

The panel uses multiparametric flow cytometry to accurately identify and classify leukaemia cells in bone marrow or peripheral blood. It analyses surface markers (CD antigens) and cytoplasmic proteins to distinguish AML, ALL, mixed‑phenotype leukaemia, and residual disease after therapy. This guides immediate treatment stratification.

2. How is the sample collected and is home collection available?

Sample collection is performed exclusively in a hospital setting by a DHA‑licensed phlebotomist. Bone marrow aspirate or peripheral blood draw is conducted in a controlled environment. Home collection is not available for this test due to the invasive nature of bone marrow aspiration. Immediate cold‑chain transport to the laboratory ensures sample viability.

3. When will I receive my results and what support do I get?

Results are typically delivered within 1–2 days through our secure patient portal, accompanied by a complimentary telephonic clinical guidance session. A specialist explains the immunophenotype, MRD status, and next steps, ensuring you and your treating physician have a clear action plan.

UAE Regulatory & Data Privacy Adherence

All testing at DNA Labs UAE complies with the UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is encrypted, anonymized for research, and handled in strict accordance with global privacy standards. Our DHA-licensed facility (License 1143) adheres to the highest clinical governance frameworks.

Clinical & Logistical Metadata

Test Name Acute Leukemia Panel (Multiparametric Flow Cytometry)
Price (AED) 1800
Turnaround Time 1–2 days
Sample Type / Matrix Bone marrow aspirate or peripheral blood (Hospital Extraction Only)
Methodology Used Multiparametric Flow Cytometry (EuroFlow 8‑colour panel)
ICD-10-CM Code C91.00, C92.00, C95.00
LOINC Code 58491-5
DHA Facility License & Address License 1143 · DNA Labs UAE · Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians